Program
Current as of Monday 9 November 2026, and is subject to change.
The AMC 2026 program features a broad range of speakers across multiple disciplines and concurrent sessions, organised under four key themes:
Prevention
Early Detection
Advanced Disease
Survivorship
How to read this program
Plenary
Concurrent
Panel Discussion
Poster
Late breaking
Break
Social event
Sponsored symposium
Oral abstract
Thursday 19 November · Day 1 · Pre-Conference
3:00 PM – 6:00 PM
Registration Open
Promenade, First Floor
5:00 PM – 6:30 PM
Welcome Reception
Sofis Lounge
Friday 20 November · Day 2 · Main Program
7:00 AM – 6:00 PM
Registration Open
Promenade, First Floor
7:00 AM – 8:00 AM
Breakfast
Sofis Lounge
Break8:00 AM – 8:30 AM
Welcome to Country & Conference Welcome
Grand Ballroom
8:30 AM – 9:30 AM
Early detection and precision prognostics: What's now and what's new?
Invited SpeakerFrom AI to Programmable Medicines: Engineering the Next Generation of Cancer Therapeutics
Invited Speaker9:30 AM – 9:45 AM
Time to get to Breakout Rooms / Refresh Break
Break
9:45 AM – 11:15 AM
UK experience with AI-assisted triage
Invited SpeakerImaging AI in Skin Cancer Practice
Invited SpeakerLegal and regulatory considerations when using AI in clinical practice
Invited SpeakerUsing scribes in practice
Invited SpeakerAI: The Consumer/Patient Perspective
Invited SpeakerKnown and Unknown AI Gems
Invited SpeakerPrecision Oncology Meets Precision Supportive Care: Diagnosing, Managing, and Prognosticating Cutaneous Immunotherapy Toxicities
Invited SpeakerTalk title TBC
Invited Speaker3M: Weaponised Immunity — The Westmead Experience
Invited Speaker9:45AMAchieving Equity for Patients
Chair: Olivia Cook
9:50AMReducing Barriers to Care for Rural Patients
Expanding Access to Specialist Skin Cancer Care: Supporting Rural Patients and the Evolving Role of Skin Cancer Nurses
Invited SpeakerEmma Zurawel, Melissa Sheldon
Oral Abstract
RISE4SkinCancer program: Regionally Integrated Systems Enhancement for Skin Cancer — a five-year initiative focused on improving skin cancer care in rural Victoria
Invited SpeakerLeigh Kinsman, David Glanville
10:15AMWhen Treatment Becomes the Challenge: Severe Multisystem Immunotherapy Complications in Advanced Melanoma
Panel discussion led by Andrew Haydon
Case Study
Patient Video
Faecal Microbiota Transplantation (FMT) as a treatment for colitis
Steven Nicolaides
Diet Therapy for ICI Colitis: Exclusive Enteral Nutrition Project
Jessica Fitzpatrick
Complexities of Melanoma Nurse Management: Preparing the Workforce for Current and Emerging Therapies
Donna Milne
11:05AMQ & A
11:15 AM – 11:45 AM
Poster
IGFBP2 is Elevated in BAP1-deficient UM and is Associated with Better Survival under Nutrient Stress
PosterPoster
Enrolling and Retaining Cohort Study Participants in Regional NSW - Insights From Our Experience
PosterOlga K Pawlik
Poster
11:15 AM – 11:45 AM
Morning Tea & Networking
Promenade, First Floor
Break11:45 AM – 1:15 PM
Changing the advertising code one submission at a time
Invited SpeakerWhat does it take to reach an audience with a media campaign in times of distraction
Invited SpeakerThe Spot: When art becomes a tool for melanoma awareness.
Invited SpeakerMaking UV Visible: The Sunburnt Car Project
Invited SpeakerSun protection and TikTok
Invited SpeakerPanel Discussion: Sun, Media & Public Communications
Panel Discussion10-things I hate about: Melanoma overdiagnosis
Invited SpeakerClinician perspectives for: Melanoma overdiagnosis
Invited SpeakerManaging overdiagnosis: lessons from Australia's national cancer screening programs
Invited SpeakerIt's just the price we pay? A Health Economic perspective on Melanoma Overdiagnosis
Invited SpeakerMelanoma? Now what? Consumer perspectives.
Invited SpeakerPathological Aspects of Overdiagnosis
Invited SpeakerPanel Discussion: Collaborative Solutions to Overdiagnosis
Panel DiscussionEnvironmentally stressed drug-naive melanoma cells share a molecular signature with drug-tolerant and drug-resistant cells
Invited SpeakerEvaluating Insulin-like Growth Factor Binding 2 (IGFBP2) as a Mediator of Metastasis and Therapeutic Vulnerability in Uveal Melanoma
Invited SpeakerIFNɣ promotes progression of nodal disease in metastatic melanoma
Invited Speaker1:15 PM – 2:15 PM
Lunch & Networking Break
Sofis Lounge
Break1:35 PM – 1:55 PM
Innovations in 3D imaging
Innovations in skin imaging – global research endeavours
Panel discussion speakers:
Doug Canfield — Canfield Scientific
Richard Martin — Surgeon, Auckland
Michelle Pearce — General Practitioner, Toorak
2:15 PM – 3:45 PM
Molecular evidence of UV causation at cellular level
Invited SpeakerSunscreen labelling and what consumers understand
Invited SpeakerSunscreen and Vitamin D: results from the Sun-D Trial
Invited SpeakerMolecular Causation
Invited SpeakerPublic interest and media stories - CHOICE report and other sunscreen interest stories in the media
Invited Speaker3:15 PMOral Abstract
Panel Discussion: UV and Sunscreen: Science vs Fiction
Panel DiscussionShould we perform skin checks
Invited SpeakerMargins for invasive melanoma
Invited SpeakerAdjuvant immunotherapy for sentinel node positive disease
Invited SpeakerSelective lymph node resection vs total lymphadenectomy after neoadjuvant drug therapy
Invited Speaker3:15 PMOral Abstract
AI-Derived Biomarkers from Whole Slide Imaging for Melanoma Prognostication
Invited Speaker2:45 PMOral Abstract
3:00 PMOral Abstract
3:10 PMOral Abstract
3:20 PMOral Abstract
3:45 PM – 4:15 PM
Afternoon Tea & Networking
Sofis Lounge
Break4:15 PM – 5:15 PM
The Evolution of Skin Cancer
Invited SpeakerChanging the narrative: regular sunscreen use increases the risk of vitamin D deficiency
Invited Speaker5:15 PM – 6:00 PM
Panel Discussion
Panel DiscussionPanellists: Vanessa Morgan, Grace Brown, Peter Soyer, Craig Sinclair & Glenn McLeay
Chair: Mike Hill
7:00 PM – 11:00 PM
Conference Dinner
Melbourne Cricket Ground (MCG)
Saturday 21 November · Day 3 · Main Program
7:00 AM – 5:00 PM
Registration Open
Promenade, First Floor
7:00 AM – 8:00 AM
Updates in the clinical & translational management of Merkel Cell Carcinoma
Speakers:
Shahneen Sandhu (Chair) — Peter MacCallum Cancer Centre
Jürgen Becker — University Hospital Essen
Richard Tothill — University of Melbourne
8:30 AM – 10:30 AM
Sunscreen: the burning topic in 2026
Invited SpeakerThe future of skin checks: can technology and A.I. help?
Invited SpeakerNew medicines, new paradigms: the evolving treatment landscape in melanoma and skin cancer
Invited SpeakerAdvocacy Workshop: Lived Experience is Expertise: Advocacy & Influence
Invited SpeakerMelanocytic Lesions in Focus: Melanocytomas, Lentigo Maligna and Clinical Vignettes – A Multidisciplinary Clinicopathological Discussion
Panel DiscussionBeyond Checkpoint Inhibitors: The Emerging Role of TIL Therapy in Melanoma
Invited SpeakerBeyond Checkpoint Inhibitors: T-Cell Engager Therapy in Melanoma
Invited SpeakerQ & A
Developing the next generation of tumour-infiltrating lymphocyte therapies for melanoma
Invited SpeakerUnderstanding the role of gut microbiota in T cell immunity against melanoma
Invited Speaker10:30 AM – 11:00 AM
Morning Tea & Networking
Promenade, First Floor
Break10:30 AM – 11:00 AM
Poster
Poster
Poster
Poster
Poster
11:00 AM – 12:00 PM
Tissue specific metabolic cues driving melanoma metastasis and anti-tumour immunity
Invited SpeakerFrom Immune States to Immune Niches: Tertiary Lymphoid Structures in Merkel Cell Carcinoma Immunotherapy
Invited Speaker12:00 PM – 12:30 PM
12:00 PM
Five-year survival with tebentafusp in previously untreated metastatic uveal melanoma in a phase 3 trial
Oral AbstractMark Shackleton
12:30 PM – 1:30 PM
Lunch & Networking Break
Promenade, First Floor
Break1:05 PM – 1:25 PM
RELATIVITY in the Real World: Real world outcomes with nivolumab and relatlimab in metastatic melanoma
A/Prof Rachel Roberts-Thomson presents real-world outcomes with first-line nivolumab + relatlimab in metastatic melanoma from two tertiary centres in South Australia, connecting trial evidence with Australian practice.
Speaker:
Rachel Roberts-Thomson — The Queen Elizabeth Hospital & Cancer Care Adelaide
1:30 PM – 3:30 PM
Update from the national targeted melanoma screening roadmap
Invited SpeakerModelling a potential screening program
Invited SpeakerACEMID cohort characteristics and excision outcomes
Invited Speaker2:30 PMOral Abstract
2:40 PMOral Abstract
2:50 PMOral Abstract
Panel Discussion: Towards a National Targeted Screening Program
Panel DiscussionPanel Discussion: What is ideal supportive/survivorship care post systemic therapy?
Panel DiscussionCardiovascular Risk in Long-Term Melanoma Survivorship after Immunotherapy
Invited SpeakerThe Role of Exercise in Patients Receiving Immunotherapy
Invited SpeakerBeyond Survival: Caring for the Psychological Impact of Melanoma
Invited Speaker2:40 PMOral Abstract
2:50 PM
The melanoma school: safe and effective discharge of early-stage melanoma patients to community care
Oral AbstractMPA nurse-led survivorship service and role in providing survivorship care beyond the acute setting
Invited SpeakerMechanisms of tumorigenesis in acral melanoma
Invited SpeakerNail apparatus melanoma with comparison of biopsy technique
Invited SpeakerPeriocular melanoma: Management challenges
Invited SpeakerOcular melanoma: diagnostic and therapeutic challenges
Invited SpeakerRoderick O'Day
Ocular melanoma therapies and clinical trials
Invited Speaker3:30 PM – 3:45 PM
Time to Get to Plenary Room / Refresh Break
Break
3:45 PM – 4:30 PM
Individualised neoantigen vaccine therapy in melanoma
Invited SpeakerCuring the Third Space
Invited Speaker4:30 PM – 4:45 PM
Award Presentations & Closing Remarks
Grand Ballroom